Warning letter
West Coast Laboratories Inc: warning letter of Sep 15, 2014
FDA warning letter 424214 · Los Angeles District Office
Key facts
| Reference number | 424214 |
|---|---|
| Company | West Coast Laboratories Inc |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Sep 15, 2014 |
| Posted date | Sep 23, 2014 |
| Issuing office | Los Angeles District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111, 111.83, 111.103, 111.127, 111.27(b), 111.70(a), 111.70(b), 111.75(a)(2)(ii), 111.83(b)(4), 111.210(f), 111.210(g), 111.210(h)(2) and 16 more |
| Inspection city | Gardena |
| Inspection ZIP | 90248 |
| Inspection start date | Feb 4, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: